A detailed history of Quarry LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Quarry LP holds 2,500 shares of NBIX stock, worth $314,125. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,500
Previous 22 11263.64%
Holding current value
$314,125
Previous $3.03 Million 9409.74%
% of portfolio
0.07%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$114.58 - $153.15 $283,929 - $379,505
2,478 Added 11263.64%
2,500 $288 Million
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $2,878 - $3,150
22 New
22 $3.03 Million
Q4 2023

Feb 14, 2024

SELL
$106.07 - $132.76 $169,499 - $212,150
-1,598 Reduced 84.19%
300 $39.5 Million
Q3 2023

Nov 14, 2023

BUY
$94.02 - $117.1 $178,449 - $222,255
1,898 New
1,898 $214 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.